Dow Up 0.11% Nasdaq Up 0.50%

OncoMed Pharmaceuticals, Inc. (OMED)

-NasdaqGS
20.29 Down 1.29(5.98%) Aug 29, 4:00PM EDT
Prev Close:21.58
Open:21.80
Bid:N/A
Ask:20.87 x 1000
1y Target Est:43.20
Beta:1.637
Next Earnings Date:N/A
Day's Range:20.00 - 21.80
52wk Range:12.07 - 42.34
Volume:231,326
Avg Vol (3m):178,095
Market Cap:603.83M
P/E (ttm):N/A
EPS (ttm):-1.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OMEDDown 5.98%603.83M
STMLUp 1.26%146.03M
VSTMDown 1.36%225.08M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.35
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem Cells (CSCs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback